Prolonged venous hemodiafiltration and hemoperfusion with polymixin in fulminant meningococcal disease: A case report

Konstantin V. Serednyakov , Yurii S. Aleksandrovich , Konstantin V. Pshenisnov , Alexandr I. Konev , Michail Ya. Ioffe

Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care ›› 2023, Vol. 13 ›› Issue (4) : 591 -598.

PDF
Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care ›› 2023, Vol. 13 ›› Issue (4) : 591 -598. DOI: 10.17816/psaic1567
Case reports
research-article

Prolonged venous hemodiafiltration and hemoperfusion with polymixin in fulminant meningococcal disease: A case report

Author information +
History +
PDF

Abstract

Fulminate meningococcal infection is one of the most formidable life-threatening conditions in children, accompanied by a high probability of complications and adverse outcomes, including disability, irreversible damage to the central nervous system, and death. The key link in the pathogenesis of this condition is the massive release of endotoxins by the pathogen and total damage to the endothelium of all vessels, which underlies the development of septic shock and all complications. The use of extracorporeal hemocorrection methods is one of the most effective methods of treating fulminate meningococcal infection; however, despite the undoubted therapeutic effect, they are not included in the recommendations of a high level of evidence and are rarely used in routine clinical practice and, in most cases, only in the terminal phase of the disease. The study presented the characteristics of the course of generalized meningococcal infection in a 7-year-old child, including intensive care measures. Particular attention was paid to assessing the severity of the condition and the effectiveness of extracorporeal hemocorrection methods. The child’s condition upon admission to the intensive care unit was 11 points according to the pSOFA scale, which indicated the presence of decompensated multiorgan dysfunction and was the basis for prolonged venovenous hemodiafiltration. Based on the results of the endotoxin activity assay (0.67 units), hemoperfusion with polymyxin was conducted. During therapy, the patient’s condition stabilized. Sixty-eight hours after admission, medical support for hemodynamics was discontinued, and the parameters of invasive mechanical ventilation were reduced. On day 7 of treatment, the patient was extubated, and the events of respiratory distress did not increase over time. On day 8 after admission, with full compensation of all vital functions following ischemic damage and deep necrosis of the tissues of the lower extremities, the patient was transferred to a multidisciplinary surgical hospital for further treatment. Early informed use of extracorporeal hemocorrection techniques contributes to the rapid regression of septic shock events and recovery of the patient, demonstrating the high efficacy of the methods used and the need for further multicenter randomized trials to routinely use these therapies in clinical practice.

Keywords

fulminate meningococcal infection / sepsis / septic shock / multiple organ failure / extracorporeal hemocorrection / outcome / case report / children

Cite this article

Download citation ▾
Konstantin V. Serednyakov, Yurii S. Aleksandrovich, Konstantin V. Pshenisnov, Alexandr I. Konev, Michail Ya. Ioffe. Prolonged venous hemodiafiltration and hemoperfusion with polymixin in fulminant meningococcal disease: A case report. Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care, 2023, 13(4): 591-598 DOI:10.17816/psaic1567

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Aleksandrovich YuS, Pshenisnov KV, Gordeev VI. Intensivnaya terapiya kriticheskikh sostoyanii u detei. Titova LA, editor. Saint Petersburg: N-L, 2014. 976 p. (In Russ.)

[2]

Александрович Ю.С., Пшениснов К.В., Гордеев В.И. Интенсивная терапия критических состояний у детей / под ред. Л.А. Титовой. Санкт-Петербург: Н-Л, 2014. 976 с.

[3]

Aleksandrovich YuS, Pshenisnov KV, Gordeev VI. Intensivnaya terapiya kriticheskikh sostoyanii u detei. Titova LA, editor. Saint Petersburg: N-L, 2014. 976 p. (In Russ.)

[4]

Yushchuk ND. Infektsionnye bolezni. Natsional’noe rukovodstvo. Kratkoe izdanie. Yushchuk ND, Vengerov YuYa, editors. Moscow: GEOTAR-Media, 2022. 848 p. (In Russ.)

[5]

Ющук Н.Д. Инфекционные болезни. Национальное руководство. Краткое издание / под ред. Н.Д. Ющука, Ю.Я. Венгерова. Москва: ГЭОТАР-Медиа, 2022. 848 с.

[6]

Yushchuk ND. Infektsionnye bolezni. Natsional’noe rukovodstvo. Kratkoe izdanie. Yushchuk ND, Vengerov YuYa, editors. Moscow: GEOTAR-Media, 2022. 848 p. (In Russ.)

[7]

Brady RC. Meningococcal infections in children and adolescents: update and prevention. Adv Pediatr. 2020;67:29–46. DOI: 10.1016/j.yapd.2020.03.007

[8]

Brady R.C. Meningococcal infections in children and adolescents: update and prevention // Adv Pediatr. 2020. Vol. 67. P. 29–46. DOI: 10.1016/j.yapd.2020.03.007

[9]

Brady RC. Meningococcal infections in children and adolescents: update and prevention. Adv Pediatr. 2020;67:29–46. DOI: 10.1016/j.yapd.2020.03.007

[10]

Medeiros I, Reis Melo A, Baptista V, et al. Meningococcemia: rare but life-threatening. BMJ Case Rep. 2018;2018:bcr2018226914. DOI: 10.1136/bcr-2018-226914

[11]

Medeiros I., Reis Melo A., Baptista V., et al. Meningococcemia: rare but life-threatening // BMJ Case Rep. 2018. Vol. 2018. ID bcr2018226914. DOI: 10.1136/bcr-2018-226914

[12]

Medeiros I, Reis Melo A, Baptista V, et al. Meningococcemia: rare but life-threatening. BMJ Case Rep. 2018;2018:bcr2018226914. DOI: 10.1136/bcr-2018-226914

[13]

Lekmanov AU, Mironov PI, Aleksandrovich YuS, et al. Sepsis in children: federal clinical guideline (draft). Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 2021;11(2):241–292. (In Russ.) DOI: 10.17816/psaic969

[14]

Лекманов А.У., Миронов П.И., Александрович Ю.С., и др. Сепсис у детей: федеральные клинические рекомендации (проект) // Российский вестник детской хирургии, анестезиологии и реаниматологии. 2021. Т. 11, № 2. С. 241–292. DOI: 10.17816/psaic969

[15]

Lekmanov AU, Mironov PI, Aleksandrovich YuS, et al. Sepsis in children: federal clinical guideline (draft). Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 2021;11(2):241–292. (In Russ.) DOI: 10.17816/psaic969

[16]

rospotrebnadzor.ru [Internet]. Gosudarstvennyi doklad «O sostoyanii sanitarno-ehpidemiologicheskogo blagopoluchiya naseleniya v RF v 2020 g.» MFS po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka [cited: 2023 Oct 24]. Available at: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=14933 (In Russ.)

[17]

rospotrebnadzor.ru [Электронный ресурс]. Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в РФ в 2020 г.» МФС по надзору в сфере защиты прав потребителей и благополучия человека [дата обращения: 24.10.2023]. Режим доступа: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=14933

[18]

rospotrebnadzor.ru [Internet]. Gosudarstvennyi doklad «O sostoyanii sanitarno-ehpidemiologicheskogo blagopoluchiya naseleniya v RF v 2020 g.» MFS po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka [cited: 2023 Oct 24]. Available at: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=14933 (In Russ.)

[19]

Angus DC, Barnato AE, Bell D, et al. A systemic revive and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med. 2015;41(9):1549–1560. DOI: 10.1007/s00134-015-3822-1

[20]

Angus D.C., Barnato A.E., Bell D., et al. A systemic revive and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators // Intensive Care Med. 2015. Vol. 41, No. 9. Р. 1549–1560. DOI: 10.1007/s00134-015-3822-1

[21]

Angus DC, Barnato AE, Bell D, et al. A systemic revive and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med. 2015;41(9):1549–1560. DOI: 10.1007/s00134-015-3822-1

[22]

Boeddha NP, Bycroft T, Nadel S, Hazelzet JA. The inflammatory and hemostatic response in sepsis and meningococcemia. Crit Care Clin. 2020;36(2):391–399. DOI: 10.1016/j.ccc.2019.12.005

[23]

Boeddha N.P., Bycroft T., Nadel S., Hazelzet J.A. The inflammatory and hemostatic response in sepsis and meningococcemia // Crit Care Clin. 2020. Vol. 36, No. 2. P. 391–399. DOI: 10.1016/j.ccc.2019.12.005

[24]

Boeddha NP, Bycroft T, Nadel S, Hazelzet JA. The inflammatory and hemostatic response in sepsis and meningococcemia. Crit Care Clin. 2020;36(2):391–399. DOI: 10.1016/j.ccc.2019.12.005

[25]

Brandtzaeg P, van Deuren M. Classification and pathogenesis of meningococcal infections. In: Christodoulides M, editor. Neisseria meningitidis. Methods in Molecular Biology. Vol 799. Humana, Totowa, NJ, 2012. P. 21–35. DOI:10.1007/978-1-61779-346-2_2

[26]

Brandtzaeg P., van Deuren M. Classification and pathogenesis of meningococcal infections. In: Neisseria meningitidis. Methods in Molecular Biology. Vol 799. Christodoulides M., editor. Humana, Totowa, NJ, 2012. P. 21–35. DOI:10.1007/978-1-61779-346-2_2

[27]

Brandtzaeg P, van Deuren M. Classification and pathogenesis of meningococcal infections. In: Christodoulides M, editor. Neisseria meningitidis. Methods in Molecular Biology. Vol 799. Humana, Totowa, NJ, 2012. P. 21–35. DOI:10.1007/978-1-61779-346-2_2

[28]

Zughaier SM. Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2. J Leukoc Biol. 2011;89(3):469–480. DOI: 10.1189/jlb.0610369

[29]

Zughaier S.M. Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2 // J Leukoc Biol. 2011. Vol. 89, No. 3. P. 469–480. DOI: 10.1189/jlb.0610369

[30]

Zughaier SM. Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2. J Leukoc Biol. 2011;89(3):469–480. DOI: 10.1189/jlb.0610369

[31]

Darton T, Guiver M, Naylor S, et al. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis. 2009;48(5):587–594. DOI: 10.1086/596707

[32]

Darton T., Guiver M., Naylor S., et al. Severity of meningococcal disease associated with genomic bacterial load // Clin Infect Dis. 2009. Vol. 48, No. 5. P. 587–594. DOI: 10.1086/596707

[33]

Darton T, Guiver M, Naylor S, et al. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis. 2009;48(5):587–594. DOI: 10.1086/596707

[34]

Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(S1):10–67. DOI: 10.1007/s00134-019-05878-6

[35]

Weiss S.L., Peters M.J., Alhazzani W., et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children // Intensive Care Med. 2020. Vol. 46, No. S1. P. 10–67. DOI: 10.1007/s00134-019-05878-6

[36]

Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(S1):10–67. DOI: 10.1007/s00134-019-05878-6

[37]

Nishizaki N, Nakagawa M, Hara S, et al. Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant. Pediatr Int. 2016;58(5):411–414. DOI: 10.1111/ped.12825

[38]

Nishizaki N., Nakagawa M., Hara S., et al. Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant // Pediatr Int. 2016. Vol. 58, No. 5. P. 411–414. DOI: 10.1111/ped.12825

[39]

Nishizaki N, Nakagawa M, Hara S, et al. Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant. Pediatr Int. 2016;58(5):411–414. DOI: 10.1111/ped.12825

[40]

Yaroustovsky M, Abramyan M, Rogalskaya E, Komardina E. Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery. Blood Purif. 2021;50(2):222–229. DOI: 10.1159/000510126

[41]

Yaroustovsky M., Abramyan M., Rogalskaya E., Komardina E. Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery // Blood Purif. 2021. Vol. 50, No. 2. P. 222–229. DOI: 10.1159/000510126

[42]

Yaroustovsky M, Abramyan M, Rogalskaya E, Komardina E. Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery. Blood Purif. 2021;50(2):222–229. DOI: 10.1159/000510126

[43]

Aleksandrovich YuS, Serednyakov KV, Pshenisnov KV. Extracorporeal hemocorrection in complex therapy of septic shock in children. Russian Journal of Anesthesiology and Reanimatology. 2021;(4):110-117. (In Russ.) DOI: 10.17116/anaesthesiology2021041110

[44]

Александрович Ю.С., Середняков К.В., Пшениснов К.В. Экстракорпоральная гемокоррекция в комплексной терапии септического шока у детей // Анестезиология и реаниматология. 2021. № 4. С. 110–117. DOI: 10.17116/anaesthesiology2021041110

[45]

Aleksandrovich YuS, Serednyakov KV, Pshenisnov KV. Extracorporeal hemocorrection in complex therapy of septic shock in children. Russian Journal of Anesthesiology and Reanimatology. 2021;(4):110-117. (In Russ.) DOI: 10.17116/anaesthesiology2021041110

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

158

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/